Heyholder

This is an amended filing · View original →

‹ Back to the disclosure you were reading

ADBIOTECH Co.,Ltd. KRW 1.0 billion convertible bond issue to fund stake purchase, payment date corrected

ADBIOTECH Co.,Ltd.· Material Event ReportAmended

AI summary · Not investment advice

The company sells bonds that can later be turned into shares to borrow KRW 1.0 billion; if all are converted, 1,000,000 new shares (3.11% of current shares) would be created.

Total face value

Amended

KRW 1.0 billion

Before amendment KRW 10.3 billion

Key facts

Acquisition of other securities
KRW 1.0 billion · Amended
% of total shares
3.11% · Amended
Convertible shares
1,000,000 shares · Amended
Conversion period
Nov 20, 2027 – Oct 20, 2029
Coupon rate
6.0%
Bond type
Series 12 bearer-type unsecured private convertible bond · Amended
Yield to maturity
6.0%
Maturity date
Nov 20, 2029Before correction: November 11, 2029
Call option limit
Up to KRW 500 million (Call Option 50%) · Amended
First put date
Nov 20, 2027Monthly thereafter
Payment date
Nov 20, 2026Before correction: November 11, 2026
Board resolution date
Oct 29, 2026 · Amended

Earlier Material Event Report filings from this company

Filings of the same type
FiledTitleKey figure · Note
26.10.30[Amended] Material Event ReportKRW 11.3 billion · Previously KRW 5.5 billion · 17.34% of total shares · 43.87% including outstanding bonds
26.10.30[Amended] Material Event ReportKRW 2.0 billion · 4.84% of total shares · 36.42% including outstanding bonds
Show Korean comments

Comments

No comments yet

Comments from shareholders will appear here.